MAGEA4 and neoplasm: The MAGEA4 expression increased significantly with the following parameters: age (>70 years; P ≤ 0.001); advanced disease stage (FIGO >II; P = 0.001); lymph node involvement (P = 0.026), and tumor grading (P < 0.001) (Supplementary Table 1).